354 related articles for article (PubMed ID: 32499757)
1. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
Colleluori G; Chen R; Turin CG; Vigevano F; Qualls C; Johnson B; Mediwala S; Villareal DT; Armamento-Villareal R
Front Endocrinol (Lausanne); 2020; 11():277. PubMed ID: 32499757
[No Abstract] [Full Text] [Related]
2. Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism.
Barnouin Y; Armamento-Villareal R; Celli A; Jiang B; Paudyal A; Nambi V; Bryant MS; Marcelli M; Garcia JM; Qualls C; Villareal DT
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1096-e1110. PubMed ID: 33351921
[TBL] [Abstract][Full Text] [Related]
3. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
Leder BZ; Finkelstein JS
Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
[TBL] [Abstract][Full Text] [Related]
4. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
Dias JP; Melvin D; Simonsick EM; Carlson O; Shardell MD; Ferrucci L; Chia CW; Basaria S; Egan JM
Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809
[TBL] [Abstract][Full Text] [Related]
5. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen.
Gava G; Armillotta F; Pillastrini P; Giagio S; Alvisi S; Mancini I; Morselli PG; Seracchioli R; Meriggiola MC
J Sex Med; 2021 Mar; 18(3):646-655. PubMed ID: 33531255
[TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.
Francomano D; Bruzziches R; Barbaro G; Lenzi A; Aversa A
J Endocrinol Invest; 2014 Apr; 37(4):401-11. PubMed ID: 24639122
[TBL] [Abstract][Full Text] [Related]
8. Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia.
Loves S; de Jong J; van Sorge A; Telting D; Tack CJ; Hermus A; Westerterp K; de Boer H
Eur J Endocrinol; 2013 Nov; 169(5):705-14. PubMed ID: 23949882
[TBL] [Abstract][Full Text] [Related]
9. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lifestyle Intervention on the Hormonal Profile of Frail, Obese Older Men.
Armamento-Villareal R; Aguirre LE; Qualls C; Villareal DT
J Nutr Health Aging; 2016 Mar; 20(3):334-40. PubMed ID: 26892583
[TBL] [Abstract][Full Text] [Related]
11. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
Burnett-Bowie SA; McKay EA; Lee H; Leder BZ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4785-92. PubMed ID: 19820017
[TBL] [Abstract][Full Text] [Related]
12. Hypogonadal Men with Higher Body Mass Index have Higher Bone Density and Better Bone Quality but Reduced Muscle Density.
Aguirre LE; Colleluori G; Dorin R; Robbins D; Chen R; Jiang B; Qualls C; Villareal DT; Armamento-Villareal R
Calcif Tissue Int; 2017 Dec; 101(6):602-611. PubMed ID: 28856390
[TBL] [Abstract][Full Text] [Related]
13. High aromatase activity in hypogonadal men is associated with higher spine bone mineral density, increased truncal fat and reduced lean mass.
Aguirre LE; Colleluori G; Fowler KE; Jan IZ; Villareal K; Qualls C; Robbins D; Villareal DT; Armamento-Villareal R
Eur J Endocrinol; 2015 Aug; 173(2):167-74. PubMed ID: 26142101
[TBL] [Abstract][Full Text] [Related]
14. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
Burnett-Bowie SA; Roupenian KC; Dere ME; Lee H; Leder BZ
Clin Endocrinol (Oxf); 2009 Jan; 70(1):116-23. PubMed ID: 18616708
[TBL] [Abstract][Full Text] [Related]
15. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
16. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery.
Pellitero S; Olaizola I; Alastrue A; Martínez E; Granada ML; Balibrea JM; Moreno P; Serra A; Navarro-Díaz M; Romero R; Puig-Domingo M
Obes Surg; 2012 Dec; 22(12):1835-42. PubMed ID: 22923309
[TBL] [Abstract][Full Text] [Related]
18. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
19. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters.
Dias JP; Shardell MD; Carlson OD; Melvin D; Caturegli G; Ferrucci L; Chia CW; Egan JM; Basaria S
Andrology; 2017 Jan; 5(1):31-40. PubMed ID: 27792869
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
Saad F; Yassin A; Doros G; Haider A
Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]